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A Commentary on
Short-Chain Alcohols Upregulate GILZ Gene Expression and Attenuate LPS-Induced Septic
Immune Response
by Ng, H. P., Jennings, S., Nelson, S., and Wang, G. (2020). Front. Immunol. 11:53.
doi: 10.3389/fimmu.2020.00053
We read with great interest the paper by Ng et al. on the effects of short chain alcohols on
glucocorticoid-induced leucine zipper (GILZ) gene expression and lipopolysaccharide-induced
(LPS) cytokine production byHumanMono-Mac-6 cells and LPS-induced septic immune response
in C57BL/6 mice (1). The authors concluded that short chain alcohols, such as ethanol, propanol
and isopropanol (2-propanol), upregulate GILZ gene expression, and suppress host inflammatory
response to LPS in a dose dependent manner (1). These findings are potentially important
because these processes play an important role in host defense mechanisms against pathogenic
microorganisms (2–4). Based on their findings the authors suggested that short chain alcohols can
be used to alleviate LPS-induced septic shock (1). However, we believe that the results published
by Ng et al. are not only of clinical but also of public health relevance. Short chain alcohols, also
known aliphatic alcohols (AAs), including methanol and higher alcohols containing more than
two carbon atoms such as 1- and 2-propanol, 1- and 2-butanol, isobutanol, and isoamyl alcohol
are found in many legally and illegally produced alcoholic beverages, including beer, wine, and
spirits (5–12). Very large portion of the population is potentially exposed to these substances,
with the latest available data from the World Health Organization, from 2016, reporting that 2.34
billion people worldwide consume alcoholic beverages, with a global annual average adult per capita
alcohol consumption from legal and illegal sources was 4.7 and 1.6 l, respectively (13). Therefore,
toxicologists and public health researchers have expressed concern about potential health risks
associated with consumption of alcoholic beverages containing AAs (5–10). Although AAs are
present in all types of alcoholic beverages, their concentration is typically higher in distilled spirits
than in beer and wine (6, 12).
The adverse effects of ethanol on the liver, gastrointestinal, nervous, and cardiovascular systems
are well-known but acute and chronic alcohol consumption have also been found to cause
immunotoxicity (14–21). Consequently, heavy alcohol use has been associated with increased
susceptibility to bacterial and viral infections and higher morbidity and mortality from a number
of infectious diseases including tuberculosis, pneumonia, human immunodeficiency virus-1, and
hepatitis C infections (16, 19, 20). While the health effects of ethanol consumption alone are an
important public health concern, less attention has been paid to the possible immunotoxic effects
of AAs found in alcoholic beverages.
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We have previously shown that AAs can decrease superoxide-
anion production by human granulocytes and inhibit
phagocytosis by human granulocytes and monocytes in a
concentration dependent manner and, when combined with
ethanol, they caused a further decrease in phagocytic activity
(22–24). We have found similar effects when granulocytes
and monocytes were exposed to metabolites of AAs including
formaldehyde, 1-propanal, acetone, 1-butanal, and 2-butanone
(25). We have also calculated that blood concentrations of
AAs and their metabolites could reach levels sufficient to
decrease phagocytosis by granulocytes and monocytes in a
clinically meaningful way in heavy users of distilled spirits
(24, 25). Thus, AAs and their metabolites may contribute to
increased susceptibility to infectious diseases (22–25). Our
population-based risk assessment demonstrated that, in addition
to ethanol, exposure to methanol, 1-propanol, 1-butanol, and
isoamyl alcohol from distilled spirits posed a health risk for
heavy alcohol users (26). In light of these and previous findings
on immunotoxic effects of AAs, the results obtained by Ng et al.
deserves wider attention.
In conclusion, we encourage the authors to extend their
research to provide a better understanding of the role
of AAs separately and in combination in molecular and
cellular mechanisms responsible for short chain alcohol-
induced immunotoxicity.
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